ARTIVA BIOTHERAPEUTICS INC ARTV
COM · Common Stock · CUSIP 04317A107
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- HeadquartersSan Diego, CA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 24.5m as of 2025-10-31, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $4.29.
Trends to Q4 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2024 | 50 |
| Q4 2024 | 58 |
| Q1 2025 | 54 |
| Q2 2025 | 49 |
| Q3 2025 | 40 |
| Q4 2025 | 34 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2024 | 25 | 7 |
| Q1 2025 | 24 | 18 |
| Q2 2025 | 21 | 33 |
| Q3 2025 | 14 | 30 |
| Q4 2025 | 9 | 27 |
Biggest buyers
| TWO SIGMA INVESTMENTS, LP | Added | +124.5k |
| VANGUARD GROUP INC | Added | +86.9k |
| MARSHALL WACE, LLP | New | +79.6k |
| JANE STREET GROUP, LLC | New | +40.7k |
| RENAISSANCE TECHNOLOGIES LLC | Added | +37.1k |
| Scientech Research LLC | New | +27.8k |
| OMERS ADMINISTRATION Corp | New | +21.1k |
| UBS Group AG | Added | +15.7k |
| OSAIC HOLDINGS, INC. | New | +32 |
Biggest sellers
| CITADEL ADVISORS LLC | Sold out | -798.4k |
| venBio Partners LLC | Reduced | -500.5k |
| BNP PARIBAS FINANCIAL MARKETS | Reduced | -118.0k |
| CITIGROUP INC | Sold out | -105.6k |
| BlackRock, Inc. | Reduced | -81.9k |
| XTX Topco Ltd | Sold out | -48.0k |
| MILLENNIUM MANAGEMENT LLC | Reduced | -45.1k |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | Sold out | -39.1k |
| GOLDMAN SACHS GROUP INC | Reduced | -37.7k |
| HRT FINANCIAL LP | Sold out | -27.0k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| RA CAPITAL MANAGEMENT, L.P. 13D · may seek influence +1.3 pts · filed 2026-07-23 | 37.9% |
| GC Corp. 13D · may seek influence filed 2026-05-28 | 12.3% |
| VIKING GLOBAL INVESTORS LP 13G · passive investor new · filed 2026-05-18 | 5.4% |
Fell to 5% or below in the last year: Venrock Healthcare Capital Partners III, L.P. (4.2%, 2026-08-14), 5AM Ventures VI, L.P. (4.8%, 2026-08-10)
Insider purchases and sales in Q4 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q1 2024 | 0 | — | 0 | — | — |
| Q2 2024 | 0 | — | 0 | — | — |
| Q3 2024 | 2 | $125.0m | 0 | — | — |
| Q4 2024 | 0 | — | 0 | — | — |
| Q1 2025 | 0 | — | 0 | — | — |
| Q2 2025 | 0 | — | 0 | — | — |
| Q3 2025 | 0 | — | 1 | $69.6k | $69.6k |
| Q4 2025 | 0 | — | 1 | $193.7k | $193.7k |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2025-12-15 | Aslan Fred President and CEO, director | Sold plan | $19.1k3.2k shares |
| 2025-11-17 | Aslan Fred President and CEO, director | Sold plan | $21.5k6.4k shares |
| 2025-10-17 | Aslan Fred President and CEO, director | Sold plan | $153.0k25.5k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q4 2025
| Manager | Shares | Change |
|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. 0.43% of their portfolio | 9.9m $42.3m | Unchanged |
| 5AM Venture Management, LLC 3.17% of their portfolio | 2.4m $10.1m | Unchanged |
| Venrock Adviser, LLC 0.34% of their portfolio | 1.6m $6.9m | Unchanged |
| venBio Partners LLC 1.29% of their portfolio | 648.5k $2.8m | Reduced -500.5k |
| FRANKLIN RESOURCES INC 0.00% of their portfolio | 520.3k $2.2m | Unchanged |
| Revelation Capital Management, LLC 1.54% of their portfolio | 299.3k $1.3m | First filing |
| VANGUARD GROUP INC 0.00% of their portfolio | 246.0k $1.1m | Added +86.9k |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 217.1k $931.3k | Reduced -45.1k |
| BlackRock, Inc. 0.00% of their portfolio | 212.5k $911.8k | Reduced -81.9k |
| WELLINGTON MANAGEMENT GROUP LLP 0.00% of their portfolio | 194.1k $832.7k | Unchanged |
| TWO SIGMA INVESTMENTS, LP 0.00% of their portfolio | 144.9k $621.5k | Added +124.5k |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 116.2k $498.5k | Added +37.1k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 101.1k $434.1k | Reduced -9.8k |
| Alyeska Investment Group, L.P. 0.00% of their portfolio | 100.0k $429.0k | Unchanged |
| MARSHALL WACE, LLP 0.00% of their portfolio | 79.6k $341.3k | New |
| JANE STREET GROUP, LLC 0.00% of their portfolio | 40.7k $174.5k | New |
| UBS Group AG 0.00% of their portfolio | 36.9k $158.2k | Added +15.7k |
| STATE STREET CORP 0.00% of their portfolio | 35.8k $153.7k | Reduced -24.0k |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 35.0k $150.2k | Unchanged |
| Scientech Research LLC 0.07% of their portfolio | 27.8k $119.1k | New |
| MORGAN STANLEY 0.00% of their portfolio | 27.1k $116.1k | Reduced -15.8k |
| OMERS ADMINISTRATION Corp 0.00% of their portfolio | 21.1k $90.5k | New |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 12.1k $51.7k | Reduced -37.7k |
| PRELUDE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 10.7k $45.9k | Reduced -3.6k |
| Russell Investments Group, Ltd. 0.00% of their portfolio | 5.5k $23.6k | Unchanged |
| FMR LLC 0.00% of their portfolio | 3.6k $15.3k | Reduced -1.4k |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 1.5k $6.4k | Reduced -200 |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 1.1k $4.7k | Reduced -8.9k |
| BNP PARIBAS FINANCIAL MARKETS 0.00% of their portfolio | 542 $2.3k | Reduced -118.0k |
| MARK SHEPTOFF FINANCIAL PLANNING, LLC 0.00% of their portfolio | 400 $1.7k | Unchanged |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 339 $1.0k | Reduced -501 |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 187 $802 | Reduced -7.8k |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 113 $484 | Reduced -16.0k |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 32 $137 | New |